Comments on: Doc Quits Hospital Over Conflict Of Interest Policy

By: Pharma Conduct Guy

Pharma Conduct Guy — Wed, 27 Jan 2010 11:34:28 +0000

I have performed an analysis of GSKs payments, which you can read about and download the data in Excel format at the following link: http://blog.pharmaconduct.org/2010/01/analysis-of-gsks-speaker-and-consulting.html?src=PharmalotComments20100127

By: pharmavet

pharmavet — Tue, 26 Jan 2010 18:25:29 +0000

Sorry, meant to say that way more money can be made otside of UNIVERSITIES…

By: pharmavet

pharmavet — Tue, 26 Jan 2010 18:24:30 +0000

WAY more money can be made outside of Pharma now that universities have clamped down. When I was a post-doctoral fellow, we hardly ever saw our Dept Head. I found out along the way that he was being paid a king’s ransom by one Pharma company to promote a new therapy, including an appearance on a popular talk show that netted him five figures. He easily doubled his university salary, and this was inn the 1980’s, before the really big bucks started pouring in.

By: Anne PME

Anne PME — Tue, 26 Jan 2010 01:24:12 +0000

If he loses prestige here in the US, maybe he can move to Asia and give talks there.

Anne

By: Roj TV

Roj TV — Tue, 26 Jan 2010 00:26:34 +0000

nice topic

thank you

By: Insider

Insider — Tue, 26 Jan 2010 00:17:51 +0000

To those of you who call Dr. DuBuske a drug pusher, take a look at the GSK report (http://gsk-us.com/docs-pdf/responsibility/hcp-fee-disclosure-2q2009.pdf) only to learn that Dr. Joshua Boyce, Co-Director of the Division of Rheumatology, Immunology, and Allergy at the Brigham and Women’s Hospital in Boston is also on that same list.

If Dr. DuBuske has done “lucrative speaking and consulting gigs for Glaxo” as you say, than what is Dr. Boyce doing. Certainly not resigning from BWH!

Here is an idea for your next article…

“Doctor does not quit Brigham and speaks for pay”.

Did you overlook that one?

By: pharmavet

pharmavet — Mon, 25 Jan 2010 19:06:03 +0000

Agree with Patrons. True confessions here. Many years ago, without naming companies or drugs, my company was a major contributor to AACE (American Association of Clinical Endocrinologists). As a reward for our support, they actually allowed us to write certain clinical practice guidelines, which naturally resulted in boosted sales of our drugs. I was flabbergasted at the leeway they gave us. In this case the chickens have finally come home to roost, and the COI’S exposed. Hopefully a new day will dawn.

By: patrons99

patrons99 — Mon, 25 Jan 2010 17:33:41 +0000

Does anyone think for even a minute that most asthma/allergy CME and guidelines are not completely biased in favor of pharma? What happened to honor, conscience, and integrity? Provides yet another demonstration of my theory that many (if not most) KOLs (academic pharma-shills) cannot survive without accepting “blood money” from pharma. It’s not all downside, however. While DuBuske may have lost his sinecure, he could still make it into the Hall of Shame.

By: firebird

firebird — Mon, 25 Jan 2010 17:05:21 +0000

Let’s say 12 weeks to the quarter,then that means he has to average more than 3 talks per week. Unless this guy sees patients in the corridors of Logan, something seems wrong with this number

By: Anonymous Patient

Anonymous Patient — Mon, 25 Jan 2010 15:47:07 +0000

Sounds like this doctor was already working for big Pharma, maybe that will be his next gig….

Also sounds like patients were being used as a means to an end and not the primary concern for this doctor. It’s a real business, accrue a lot of patients into your business, keep a fair number on one drug or the other, just enough to make you look appealing to industry…then voila! travel the world at the industry expense…

By Lawrence, pretty sure your patients won’t miss you…But don’t worry, who ever takes over from you will be happy to fill your shoes with pharma. Same game, different players……